Medical Examiners and Coroners / Meda Phar maceuticals Inc. / Coleman / /
Country
United States / Spain / /
Event
Product Issues / FDA Phase / Product Recall / /
Facility
hospital EDs / Mayo Clinic / College of Problems / /
IndustryTerm
retail pharmacies / pharmaceutical / retail dispensing / federal case law / law enforcement encounters / immediate chemical precursor / pharmaceuticals / healthcare practitioners / retail prescriptions / law enforcement / decision-law enforcement problems / provider groups / retail pharma cies / retail chains / /
MedicalCondition
tremors / myoclonus / Florida drug abuse / seizures / chronic use / significant drug abuse / drug dependence / withdrawal syndrome / central nervous system depression / ataxia / respiratory failure / drug withdrawal symptoms / deliberate poisoning / withdrawal symptoms / multi-drug abuse / injuries / /
MedicalTreatment
polypharmacy / /
NaturalFeature
Fraser / /
OperatingSystem
OSE / /
Organization
DAWN Emergency Department / Supreme Court / DEPARTMENT OF JUSTICE Drug Enforcement Administration / College of Problems of Drug De / Tennessee Bureau of Investigation / National Institute on Drug Abuse / office of Administrative Law Judges / U.S. Securities and Exchange Commission / Department of Justice / Ohio State Board of Pharmacy / Subcommittee on Oversight and Investigations / Congress / Substance Abuse Mental Health Service's Administration / Florida Medical Examiners Commission / Ohio State Board of Pharmacy / and a Special Agent / Court of Appeals / House Committee on Commerce / U.S. Food and Drug Administration / Department of Health and Human Services / Drug Abuse Advisory Committee / /
Person
Howard H. Koh / Gonzales / Nabarun Dasgupta / DAWN ED / / /
Position
Attorney / driver / Executive Director / physician / General / Secretary / head / Assistant Secretary / Commissioner / Executive / Administrator / DEA counsel / representative / Attorney General / Attor ney General / e Administrator / Special Agent / /
76 FR[removed], 2011 WL[removed]F.R.) Page 1 RULES and REGULATIONS DEPARTMENT OF JUSTICE Drug Enforcement Administration 21 CFR Part[removed]Docket No. DEA-333] Schedules of Controlled Substances: Placement of Carisoprodo